A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK
- PMID: 15491289
- DOI: 10.1111/j.1365-2141.2004.05207.x
A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK
Abstract
Epidemiology data on multiple myeloma (MM) occurrence and outcome is inconsistent whilst a major limitation of randomized controlled trials is selection bias. We present a population-based analysis of patients diagnosed with MM in the South Thames area, which comprises 5.4 million adult inhabitants. A total of 855 cases of MM were ascertained between 1999 and 2000 in a collaborative project involving haematologists and the Thames Cancer Registry. The age-standardized rate was 3.29 per 100 000 and 4.82 cases per 100 000 (World Standard and European Population respectively). The median age was 73 years. The median survival for the whole group was 24 months whist it was 42 and 18 months in those aged less than 65 years and greater than 65 years respectively (P < 0.001). This population study has shown a higher incidence than previously reported in the UK and Europe and provides a benchmark for future studies. If survival is to be improved, future clinical trials and health care planning should consider patients over 65 years of age.
Similar articles
-
Multiple myeloma in north east Scotland: a review of incidence and survival over three decades.Health Bull (Edinb). 1996 May;54(3):232-40. Health Bull (Edinb). 1996. PMID: 8707567
-
Epidemiology of multiple myeloma in Taiwan: increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years.Cancer. 2007 Aug 15;110(4):896-905. doi: 10.1002/cncr.22850. Cancer. 2007. PMID: 17594697
-
Epidemiologic and age-dependent data on multiple myeloma in Austria.J Natl Cancer Inst. 1982 May;68(5):729-33. J Natl Cancer Inst. 1982. PMID: 6951084
-
Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003.Rheumatology (Oxford). 2006 Feb;45(2):187-91. doi: 10.1093/rheumatology/kei107. Epub 2005 Dec 6. Rheumatology (Oxford). 2006. PMID: 16332955 Review.
-
Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?Bone Marrow Transplant. 2006 Nov;38(9):585-92. doi: 10.1038/sj.bmt.1705486. Epub 2006 Sep 4. Bone Marrow Transplant. 2006. PMID: 16953209 Review.
Cited by
-
A rare case of renal recovery in a young patient with multiple myeloma.Case Rep Nephrol. 2013;2013:531205. doi: 10.1155/2013/531205. Epub 2013 Mar 27. Case Rep Nephrol. 2013. PMID: 24558623 Free PMC article.
-
Clinical features and treatment outcome of elderly multiple myeloma patients with impaired renal function.J Clin Lab Anal. 2019 Jun;33(5):e22888. doi: 10.1002/jcla.22888. Epub 2019 Apr 19. J Clin Lab Anal. 2019. PMID: 31004381 Free PMC article.
-
Efficacy and Safety of Anti-CD38 Monoclonal Antibodies in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Randomized Clinical Trials.J Pers Med. 2024 Mar 29;14(4):360. doi: 10.3390/jpm14040360. J Pers Med. 2024. PMID: 38672988 Free PMC article. Review.
-
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory values.Theranostics. 2017 Jan 1;7(1):205-212. doi: 10.7150/thno.16576. eCollection 2017. Theranostics. 2017. PMID: 28042328 Free PMC article.
-
The value of routine biopsy during percutaneous kyphoplasty for vertebral compression fractures.PLoS One. 2014 Dec 19;9(12):e115417. doi: 10.1371/journal.pone.0115417. eCollection 2014. PLoS One. 2014. PMID: 25526360 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical